- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Nasdaq
Wall Street JournalEN
S
SUPN
Supernus Pharma
50.86
-0.49-0.95%After Hours: 51.42 +0.56 +1.10%17:22 02/20 EST
OPEN/PREV CLOSE51.48/51.35
TODAY RANGE50.19-51.88
VOL758.57K
MARKET CAP2.92B
52 WEEK RANGE29.16-57.65
AVG VOL (3M)670.94K
% TURNOVER1.32%
TURNOVER--
P/E (TTM)-149.2371
% RANGE3.30%
EPS(TTM)-0.3408
P/E(FORWARD)-62.0244
P/B2.768
BVPS18.38
DIVIDEND--
P/S4.284
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.79B
SHARES OUTSTANDING57.34M
NEXT EARNINGS02/23-02/27
FREE FLOAT54.86M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·02/06 12:02
Biogen projects 2026 revenue drop despite Q4 beat
Seeking Alpha·02/01 12:59
Supernus: Outlook For 2026 Positive, Upholding Buy Rating
TipRanks·01/28 22:49
Supernus Revises Merger Milestone Payment Obligations Agreement
TipRanks·01/28 12:39
Piper Sandler Remains a Buy on Supernus Pharmaceuticals (SUPN)
TipRanks·01/20 11:47
Bank of America Securities Remains a Buy on Supernus Pharmaceuticals (SUPN)
Seeking Alpha·01/09 17:49
Top small and mid-cap ideas with 27% average upside potential – BoA
TipRanks·01/09 12:16
Cantor Fitzgerald Remains a Buy on Supernus Pharmaceuticals (SUPN)
TipRanks·01/09 12:16
Supernus Pharmaceuticals (SUPN) Receives a Buy from Piper Sandler
Reuters·12/22/2025 21:05
Supernus Pharmaceuticals SVP Frank Mottola Reports Sale of Common Shares
Reuters·12/19/2025 21:06
Supernus Pharmaceuticals SVP Padmanabh Bhatt Reports Disposal of Common Shares
Dow Jones·12/19/2025 19:52
Supernus Pharmaceuticals on Pace for Longest Winning Streak Since July 2024 -- Data Talk
Same Industry
Name/Symbol
Change%
Price